Trial Profile
Conversion pharmacodynamic study in stable renal transplant patients receiving tacrolimus two times a day to a new formulation of tacrolimus - LCP Tacro - 1 time a day.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Pharmacodynamics
- Acronyms TACPKPD
- 07 Apr 2020 Status changed from recruiting to completed.
- 26 Feb 2018 Planned End Date changed from 1 Dec 2017 to 1 Sep 2018.
- 26 Feb 2018 Planned primary completion date changed from 1 Sep 2017 to 1 Sep 2018.